-26.7%
CLX vs BBIO
+136.9%
-163.6%
-56.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.9% | -4.7% | +3.8% | -0.9% |
| 7D | -5.9% | -3.9% | -2.0% | -5.8% |
| 30D | -17.0% | -13.4% | -3.7% | -17.0% |
| 3M | -9.6% | +7.6% | -17.1% | -9.6% |
| 6M | -21.5% | -2.4% | -19.1% | -21.5% |
| YTD | -8.8% | -5.2% | -3.6% | -8.8% |
| 1Y | -24.7% | +36.9% | -61.6% | -24.7% |
| 3Y | -35.6% | +155.2% | -190.8% | -35.5% |
| 5Y | -37.6% | +44.0% | -81.6% | -37.8% |
| All | -26.7% | +136.9% | -163.6% | -24.6% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling